Trilaciclib Injection [Cosela] Clinical Trials

1 actively recruiting trial

▼ -1 trial since August 2026

Also known as: CDK 4/6 inhibitor, G1T28

Pipeline

Phase 2: 1

Top Sponsors

Fudan University1

Indications

Myelosuppression1
Ewing Sarcoma1
Cancer1

Other1 trial

A Prospective, Randomized, Controlled Clinical Study on the Prevention of Chemotherapy Related Myelosuppression in Patients with Ewing's Sarcoma Using Trilaciclib

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.